Snapshot
Danaher Corp /De/ reported $6.84B of revenue in Q4 2025, up 4.6% year over year, with diluted EPS of $1.68 and an operating margin of 22.0%.
- Revenue
- $6.84B
- YoY growth
- +4.6%
- Diluted EPS
- $1.68
- Operating margin
- 22.0%
$6.84B
Revenue
+4.6%
YoY growth
$1.68
Diluted EPS
22.0%
Operating margin
01 Key takeaways
What management said
- •Our team's disciplined execution also enabled us to exceed our fourth quarter margin, earnings, and cash flow expectations.
- •In pharma, global monoclonal antibody production remained robust, and we were encouraged to see a modestly more favorable capital spending environment.
- •We also continued to see a recovery in pharma R&D spending, while biotech demand remained stable.
- •Academic and government demand remained muted but was stable sequentially, while clinical and applied end markets continued to perform well.
- •So with that, let's take a closer look at our full-year 2025 financial results.
- •Our adjusted operating profit margin was 28.2%, and adjusted diluted net earnings per common share of $7.80 were up 4.5%.
- •We also generated $5.3 billion of free cash flow, resulting in a free cash flow to net income conversion ratio of approximately 145%.
- •Strong free cash flow generation is one of the most important metrics at Danaher, and 2025 marks the 34th consecutive year our free cash flow to net income conversion ratio exceeded 100%.
- •Our earnings growth and strong free cash flow generation in the face of tariff-related cost pressures and significant productivity investments underscore the differentiated quality of our earnings and business models.
- •These are just a few of the innovations from across Danaher that are delivering meaningful customer impact while also driving clear financial results, including approximately 25% year-over-year growth in new product revenue.
- •Sales were $6.8 billion in the fourth quarter, and we delivered 2.5% core revenue growth.
- •High growth markets were up mid-single digits, with solid growth outside of China, more than offsetting a low single-digit decline in China.
SourcesCompany financials · earnings call
Last updated